Last checked at 
| Friday 7 May | |
| Numis Corp PLC | Half Year Results |
| International Consolidated Airlines Group SA | Q1 Results |
| InterContinental Hotels Group PLC | Q1 Results |
| Monday 10 May | |
| HgCapital Trust PLC | Q1 Results |
| Kosmos Energy Ltd | Q1 Results |
| Provident Financial Group PLC | Full Year Results |
| Smartspace Software PLC | Full Year Results |
| Victrex PLC | Half Year Results |
| Tuesday 11 May | |
| Air Partner PLC | Full Year Results |
| Angling Direct PLC | Full Year Results |
| Arrow Global Group PLC | Q1 Results |
| Coca-Cola European Partners PLC | Trading Statement |
| Morgan Advanced Materials PLC | Trading Statement |
| Treatt PLC | Half Year Results |
| WM Morrison Supermarkets PLC | Q1 Results |
| Zytronic PLC | Half Year Results |
| Wednesday 12 May | |
| TI Fluid Systems PLC | Trading Statement |
| Tui AG | Half Year Results |
| Compass Group PLC | Half Year Results |
| Coca-Cola HBC AG | Trading Statement |
| Mears Group PLC | Full Year Results |
| Stock Spirits Group PLC | Half Year Results |
| National Express Group PLC | Trading Statement |
| Vertu Motors PLC | Full Year Results |
| Airtel Africa PLC | Full Year Results |
| Vaalco Energy Inc | Q1 Results |
| Thursday 13 May | |
| 3i Group PLC | Full Year Results |
| Beazley PLC | Trading Statement |
| Brewin Dolphin Holdings PLC | Half Year Results |
| BT Group PLC | Full Year Results |
| Burberry Group PLC | Full Year Results |
| ContourGlobal PLC | Trading Statement |
| Countryside Properties PLC | Half Year Results |
| e-Therapeutics PLC | Full Year Results |
| Grainger PLC | Half Year Results |
| Greggs PLC | Trading Statement |
| Hargreaves Lansdown PLC | Trading Statement |
| Titon Holdings PLC | Half Year Results |
| TT Electronics PLC | Trading Statement |
| Valeura Energy Inc | Q1 Results |
| Copyright 2021 Alliance News Limited. All Rights Reserved. | |
2 Jul 2021 13:47
E-therapeutics meets 'key milestone' in Galapagos collaboration
(Sharecast News) - E-therapeutics has met a key milestone in its collaboration with Galapagos, a commercial-stage company specialising in the discovery and development of small-molecule medicines with novel modes of action, with a focus on inflammation, fibrosis and kidney disease, it announced on Friday.
Read more